CD4-BASED APPROACHES TO HIV-1 RECEPTOR ANTAGONISTS

被引：0
|
作者：
REINHERZ, EL
机构：
[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, IMMUNOBIOL LAB, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 1994年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [1] A Novel CD4-based Chimeric Antigen Receptor for Functional Cure of HIV
    Liu, Li
    Patel, Bhavik
    Ghanem, Mustafa
    Zheng, Zhilli
    Bundoc, Virgilio
    Morgan, Richard
    Rosenberg, Steven A.
    Dey, Barna
    Berger, Edward A.
    PROTEIN SCIENCE, 2014, 23 : 93 - 93
  • [2] Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor
    Leibman, Rachel S.
    Richardson, Max W.
    Ellebrecht, Christoph T.
    Maldini, Colby R.
    Glover, Joshua A.
    Secreto, Anthony J.
    Kulikovskaya, Irina
    Lacey, Simon F.
    Akkina, Sarah R.
    Yi, Yanjie
    Shaheen, Farida
    Wang, Jianbin
    Dufendach, Keith A.
    Holmes, Michael C.
    Collman, Ronald G.
    Payne, Aimee S.
    Riley, James L.
    PLOS PATHOGENS, 2017, 13 (10)
  • [3] SYNERGISTIC INHIBITION OF HIV-1 ENVELOP-MEDIATED CELL-FUSION BY COMBINATIONS OF CD4-BASED MOLECULES AND ANTIBODIES TO HIV-1 GP120 OR GP41
    ALLAWAY, GP
    RYDER, AM
    BEAUDRY, GA
    MADDON, PJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 25 - 25
  • [4] Current status of CD4-based therapies for prophylaxis and treatment of HIV infection
    Sinclair, JP
    Shearer, WT
    BIODRUGS, 1997, 8 (02) : 128 - 138
  • [5] Current Status of CD4-Based Therapies for Prophylaxis and Treatment of HIV Infection
    Jan P. Sinclair
    William T. Shearer
    BioDrugs, 1997, 8 : 128 - 138
  • [6] Probing the Effect of Force on HIV-1 Receptor CD4
    Perez-Jimenez, Raul
    Alonso-Caballero, Alvaro
    Berkovich, Ronen
    Franco, David
    Chen, Ming-Wei
    Richard, Patricia
    Badilla, Carmen L.
    Fernandez, Julio M.
    ACS NANO, 2014, 8 (10) : 10313 - 10320
  • [7] Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity
    Liu, Li
    Patel, Bhavik
    Ghanem, Mustafa H.
    Bundoc, Virgilio
    Zheng, Zhili
    Morgan, Richard A.
    Rosenberg, Steven A.
    Dey, Barna
    Berger, Edward A.
    JOURNAL OF VIROLOGY, 2015, 89 (13) : 6685 - 6694
  • [8] A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
    Lin, PF
    Blair, W
    Wang, T
    Spicer, T
    Guo, Q
    Zhou, NN
    Gong, YF
    Wang, HGH
    Rose, R
    Yamanaka, G
    Robinson, B
    Li, CB
    Fridell, R
    Deminie, C
    Demers, G
    Yang, Z
    Zadjura, L
    Meanwell, N
    Colonno, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) : 11013 - 11018
  • [9] Co-receptor antagonists as HIV-1 entry inhibitors
    Shaheen, F
    Collman, RG
    CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (01) : 7 - 16
  • [10] SOLUBLE CD4 INACTIVATES HIV-1 AT LOW RECEPTOR OCCUPANCY
    BERKOWER, I
    MURPHY, D
    CLINICAL RESEARCH, 1990, 38 (02): : A280 - A280
12345